Intellia Therapeutics, Inc. (NTLA) Buy Rating Reiterated Despite Share Offering Dilution

Intellia Therapeutics, Inc. (NTLA) Buy Rating Reiterated Despite Share Offering Dilution

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.